Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP458008.RAlWIoWsIqEC9dr_pDJRw8cMzsp3YrJEfP5rTWu4jIJlU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP458008.RAlWIoWsIqEC9dr_pDJRw8cMzsp3YrJEfP5rTWu4jIJlU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP458008.RAlWIoWsIqEC9dr_pDJRw8cMzsp3YrJEfP5rTWu4jIJlU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP458008.RAlWIoWsIqEC9dr_pDJRw8cMzsp3YrJEfP5rTWu4jIJlU130_provenance.
- NP458008.RAlWIoWsIqEC9dr_pDJRw8cMzsp3YrJEfP5rTWu4jIJlU130_assertion description "[We sought to determine whether administration of a MGMT blocker, O(6)-benzyl guanine (O(6)BG), at an optimal biological dose alone or in combination with gemcitabine inhibits human pancreatic cancer cell growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP458008.RAlWIoWsIqEC9dr_pDJRw8cMzsp3YrJEfP5rTWu4jIJlU130_provenance.
- NP458008.RAlWIoWsIqEC9dr_pDJRw8cMzsp3YrJEfP5rTWu4jIJlU130_assertion evidence source_evidence_literature NP458008.RAlWIoWsIqEC9dr_pDJRw8cMzsp3YrJEfP5rTWu4jIJlU130_provenance.
- NP458008.RAlWIoWsIqEC9dr_pDJRw8cMzsp3YrJEfP5rTWu4jIJlU130_assertion SIO_000772 19789303 NP458008.RAlWIoWsIqEC9dr_pDJRw8cMzsp3YrJEfP5rTWu4jIJlU130_provenance.
- NP458008.RAlWIoWsIqEC9dr_pDJRw8cMzsp3YrJEfP5rTWu4jIJlU130_assertion wasDerivedFrom befree-20140225 NP458008.RAlWIoWsIqEC9dr_pDJRw8cMzsp3YrJEfP5rTWu4jIJlU130_provenance.
- NP458008.RAlWIoWsIqEC9dr_pDJRw8cMzsp3YrJEfP5rTWu4jIJlU130_assertion wasGeneratedBy ECO_0000203 NP458008.RAlWIoWsIqEC9dr_pDJRw8cMzsp3YrJEfP5rTWu4jIJlU130_provenance.
- befree-20140225 importedOn "2014-02-25" NP458008.RAlWIoWsIqEC9dr_pDJRw8cMzsp3YrJEfP5rTWu4jIJlU130_provenance.